Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.21 USD | +2.47% | -1.49% | +2.94% |
Mar. 01 | RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating | MT |
Feb. 29 | Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.94% | 358M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ZYXI Stock
- News Zynex, Inc.
- Zynex Submits FDA Application for M-Wave Neuromuscular Electrical Stimulation Device